Bioretec Ltd – Managers’ transactions – Mirva Ekman
Bioretec Ltd | Company release | 16 November 2026 at 4:15 p.m. EET
Bioretec Oy – Managers’ Transactions
____________________________________________
Person subject to the notification requirement
Name: Mirva Ekman
Position: Other senior manager
Issuer: Bioretec Oy
LEI: 7437008736AG7HY51K13
Notification type: INITIAL NOTIFICATION
Reference number: 180721/9/9
____________________________________________
Transaction date: 2026-11-16
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Name of the instrument: Bioretec Oy, optio-ohjelma 2026A
Nature of transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 5336648 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 5336648 Volume weighted average price: 0 EUR
For additional information
Sarah van Hellenberg Hubar-Fisher
CEO
+31 6 1544 8736
sarah.hubar-fisher@bioretec.com
Panu Mikkonen
CFO
+358 50 4833 707
panu.mikkonen@bioretec.com
Certified Adviser
Nordic Certified Adviser AB, +46 70 551 67 29
Information about Bioretec
Bioretec is a globally operating Finnish medical device pioneer at the forefront of transforming orthopedic care with bioabsorbable implant technologies. The company offers two product families, Activa and RemeOs™, both based on advanced bioabsorbable materials. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
Bioretec’s Activa product family features fully bioabsorbable orthopedic implants made from a proprietary, self-reinforced PLGA both CE marked and FDA cleared for a wide range of indications.
The company’s latest innovation, the RemeOs™ product family, is based on a high-performance magnesium alloy and hybrid composite. The first RemeOs™ product market authorization was received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025. To date, the RemeOs™ product line has received three FDA Breakthrough Device Designations.
To learn more about Bioretec, visit www.bioretec.com
Share this article